The Spine Patient Outcomes Research Trial aimed to determine the comparative effectiveness of surgical care versus nonoperative care by measuring longitudinal values: outcomes, satisfaction, and costs.
D isorders of the lumbar spine-including intervertebral disk herniation (IDH), spinal stenosis (SPS), and degenerative spondylolisthesis (DS)-are common, disabling, and costly. Different stakeholders in the health care system have important questions that demand answers. Patients suffering from these problems want to know if the anxiety, risks, recovery time, and costs associated with surgery will result in better and sustained health outcomes. Physicians caring for spine patients want to give them the best information about their chances for pain relief and for regaining full functioning with or without surgery. Payers covering the costs of health care for beneficiaries with spine conditions need to know if their investment in surgical care for spine patients will be rewarded by superior health results in the short and long run.
Although the challenges of answering these questions are manifold, they are important questions that require the best answers based on available data. This paper aims to summarize available evidence from the Spine Patient Outcomes Research Trial (SPORT) by addressing 2 important questions about outcomes and costs for 3 types of spine problems. Both questions will be answered for each of the 3 spine conditions based on patient results after 2 and 4 years of follow-up. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] Outcomes and costs: how do outcomes and costs of spine patients differ depending on whether they are treated surgically versus nonoperatively? Cost-effectiveness: what is the incremental cost per quality adjusted life year (QALY) for surgery versus nonoperative care? As we answer these questions, we hope to demonstrate how the graphical presentation of data, using the clinical value compass approach, provides a parsimonious way to summarize diverse study endpoints associated with the value of health care. We show how this tool can be used to answer questions about outcomes and costs for different types of spine problems.
The data used to answer these questions come from SPORT, the large prospective, multicenter, comprehensive cohort study (ie, a concurrent, prospective, preference-based observational cohort alongside a randomized trial). Most of the literature that has heretofore been published focuses on outcomes at 2 years 4, 5, 9, 10 or at 4 years [6] [7] [8] for the 3 spine conditions. Some of the papers report health economic results using QALYs and estimates for the incremental costs per QALY conferred by surgery. [8] [9] [10] Publications from SPORT, taken as a whole, provide extensive information on a comprehensive set of data measuring case-mix factors, patient demographics, condition-specific outcomes, general health status outcomes, patient reports on their satisfaction with treatment, and the comparative cost-effectiveness of surgical versus nonsurgical care. However, it may be difficult to get a clear overall picture of the results from the vast amount of data in these numerous individual publications. The hallmark of this paper is that it uses a small set of outcome and cost results and a value compass graphical framework to efficiently communicate clinical, patient satisfaction, and economic endpoints of interest to patients, providers, and policy makers.
METHODS

Overview of Research Design
Extensive information on SPORT's study design and methods has been published previously. 4, 5, [9] [10] [11] The SPORT study followed patients from 13 medical centers in 11 states; enrollment started in March 2000 and finished in March 2005. Eligible participants were aged 18 years and older with well-defined symptoms, physical findings, and imagingconfirmed diagnoses of SPS either alone or associated with DS, or of IDH. After determining that prospective spine patients were study eligible, they were provided detailed information on the known risks and benefits of treatment alternatives that explained what was known about the risks and benefits of surgical care and nonoperative care of patients with their index condition. Patients who agreed to participate in the randomized study were assigned by chance to receive 1 of 2 treatment options-surgical care versus nonoperative care. Patients who agreed to participate but were unwilling to be randomized were entered into the concurrent observational cohort based on their treatment preference. All subsets of patients were followed to determine whether or not they actually underwent spine surgery, regardless of the group that they originally entered, and to measure a comprehensive set of outcomes. Data were collected at 6 weeks, 3 months, 6 months, 1 year, and continues to be collected annually. The randomized component of the study experienced high degrees of crossover, with substantial proportions of those randomized to nonoperative treatment eventually getting surgery and those randomized to surgery never receiving it. This limits the interpretation of an intention-to-treat analysis. Interestingly, analysis revealed a high degree of similarity in both the baseline characteristics and the outcomes of patients in the randomized and observational components of SPORT. As a result, this report is based on an "as-treated" analysis of the combined randomized and observational patients and their results at baseline and at 2 and 4 years.
Data Collection Methods
At baseline the following types of data were collected from different sources: diagnosis, spine disease status, spine disease severity, functional health status, general health status, patient demographics, descriptive variables, and comorbidities. Then, at the intervals described above, followup data were collected to measure changes in health status, patient reports on their care experiences including satisfaction with treatment results, utilization, and costs of care during the preceding time interval, and other pertinent data.
Main Outcome Measures
We selected 6 measures to answer the 2 questions that are featured in this report.
Oswestry Disability Index (ODI)
The AAOS/Modems version of the ODI uses 9 items to measure patient self-reported, disease-specific burden of illness. 12 It was selected because it has been widely accepted as a valid measure, and changes in the level of the index are considered to be clinically relevant. A change of 15 points on the ODI is considered a substantial and clinically relevant change.
Physical Function Scale (PF)
This is 1 of the 8 scales of the SF-36. [13] [14] [15] [16] The PF scale uses 10 items to estimate PF based on patient self-report. It was selected because it is valid, reliable, and sensitive to changes in underlying disease states, and among the most widely used measures of functional health. A change of 10 points on the PF is considered substantial and clinically relevant.
Patient Treatment Satisfaction (PTS)
This single-item measure reflects the individual patient's assessment of the degree to which he/she is "very satisfied" or "somewhat satisfied" with the care received; it is an indicator of the patient's perception of treatment benefit. [17] [18] [19] 
QALYs
The EuroQoL EQ-5D with US scoring was used to estimate QALYs. 20, 21 The EQ-5D uses 5 questions (mobility, self-care, pain, usual activities, and anxiety) based on patient-reported function at each of 3 levels to define 245 distinct health states. By taking time-weighted estimates of EQ-5D health state values we estimated patient changes in health-related quality of life (denoted by QALYs) for surgical treatment or nonoperative care.
Costs of Spine Care (CSC)
CSC includes 2 types of costs-direct costs associated with treatment and indirect social costs associated with having the spine condition. The direct portion of CSC was based on an estimate of the patient's direct costs of receiving spine-related care. Indirect costs were estimated by assessing lost productivity due to spine-related problems. Direct costs were based on patients' reports of utilization of major categories of health care services (eg, physician visits, emergency department visits, hospital stays, etc.); these were monetized based on applying standard national average costs associated with using these services. Indirect costs were based on patients' reports of the number of days of paid work that they either missed or had to reduce, or caregiver and homemaker expenses imposed by role limitations; these were monetized based on applying each patient's salary level to the amount of time that work was missed or limited due to their spine condition.
Incremental Cost-Effectiveness Ratio (ICER)
This metric uses the data on direct and indirect costs to provide an estimate of the additional expenses associated with gains in QALYs from surgery compared with nonoperative treatment. In general, if the cost per QALY is < $100,000, then it is often considered by health economists to be sufficiently cost-effective to merit its use in clinical practice in the United States. 22 In summary, 2 measures, ODI and PF, reflect the changes in functional health status from baseline to followup at either 24 or 48 months. PTS reflects the patient's assessment at 24-or 48-month follow-up of how much they were helped by their treatment. CSC reflects the direct and indirect costs associated with spine problems during the interval starting at baseline and extending until the point of follow-up, a time span of either 24 or 48 months. QALYs and ICERs reflect the improvement associated with treatment observed at 24 or 48 months using a single numeric value to reflect each result.
Data Analysis Methods
Data are reported based on "as-treated" patients in each of the 3 respective disease groups. This means that patients are classified by the actual treatment received (surgical vs. nonoperative care at the time of analysis and not on their original study assignment.) The treatment indicator in this analysis is treated as a time-varying covariate, with all outcomes occurring before surgery being assigned to the nonoperative group and outcomes occurring after surgery being assigned to the surgery group. The timing of the outcome is assessed relative to the date of surgery (reset clock) and the baseline data for calculating change scores is drawn from the most recent datapoint before surgery (reset baseline). 6 The outcome and cost measures described above were calculated after 2 and 4 years of follow-up observations.
Detailed descriptions of the analysis methods have been published elsewhere. [4] [5] [6] [7] [8] [9] [10] In brief, all longitudinal result measures were adjusted for important case-mix differences that existed at baseline. Primary analyses compared surgical and nonoperative treatments using changes from baseline at 2 and 4 years of follow-up using a mixed effects longitudinal regression model, which included a random individual effect to correct for associations between repeated measurements within individual patients.
Data are displayed using conventional tables as well as with graphical value compass figures. 23, 24 The basic idea behind the value compass is that the value of health care, for an individual patient or a clinical population, is a function of several factors. The compass display provides a compact way to summarize a large amount of data in a single view. Thus, the value compass has 4 major domains of value-related outcomes and each "point" on the compass displays a particular category of results. In general, the west compass point shows clinical outcomes, the north point shows functional outcomes, the east point shows patient perceptions of care, and the south point shows costs incurred by the patient: direct expenses for medical care (such as out-of-pocket payments and insurance payments) plus indirect societal costs (such as time lost from work).
The value compass displays in this report include specific measures for each domain: ODI (disease outcomes), PF (functional outcomes), PTS (patient satisfaction with care), and CSC (direct and indirect costs associated with treatment and role limitations). In addition, cost-effectiveness data on QALYs and ICERs are shown at the center of the compass display.
RESULTS
Characteristics of Patients at Baseline
The results in Table 1 show the similarities and differences across the 3 disease groups and between the surgical and nonoperative treatment groups within disease groups at baseline using the "as-treated" classification for patients.
In general, the data suggest that IDH patients tend to be substantially younger, employed, and more likely to smoke, whereas the SPS and DS patients tend to be older, retired, and less likely to smoke. IDH and SPS patients are more likely to be males, whereas DS patients are more likely to be females. The average body mass indices for all cohorts range from 27 to 29, indicating that the average patient is overweight but not obese. Surgery patients tended to have worse functional health status at baseline across all disease groups.
The baseline measures that compare surgical and nonoperative IDH patients show several pretreatment differences that were significant (P < 0.05). IDH patients in the surgery group were younger, less likely to be working full or part time, had higher body mass indices, were less likely to have joint problems or other comorbidities, tended to have worse health status (pain, ODI, PF, symptoms), were more likely to report that they were getting worse at time of enrollment, and had higher rates of L5-S1 herniation.
Similarly, there were significant differences between surgical and nonoperative SPS and DS patients at baseline. SPS and DS surgical patients were younger, scored worse on health measures (pain, ODI, PF, symptoms), and were more likely to report that they were getting worse at enrollment. However, there were no significant differences between surgical and nonoperative patients on the levels of stenosis.
The patterns revealed by Table 1 show that, because of the as-treated nature of the analysis, the treatment groups differed in several important respects. These differences underscore the importance of careful case-mix adjustment for baseline differences in the longitudinal regression models to provide a fair comparison between the treatment groups.
Differences in Outcomes and Costs at 2 and 4 Years: Surgical and Nonoperative Patients
The general pattern of results on health outcomes and costs that are contained in Table 2 suggests that at both 2 and 4 years, after adjusting for case-mix differences at baseline, patients in all 3 disease groups who were treated surgically had better health outcomes, higher levels of treatment satisfaction, and higher health care costs. Table 3 shows the unadjusted results for comparison.
With respect to the overall cost-effectiveness of care, surgical patients enjoyed greater gains in QALYs, although the differences between these gains in absolute terms were not large. As for the "bottom line" measure of cost-effectiveness, the ICERs varied greatly. At 2 years, the ICERs for IDH, SPS, and DS surgical patients were $34,355, $77,600, and $115,600, respectively, whereas the cost-effectiveness values at 4 years were $20,600, $59,400, and $64,300. Figures 1-3 display the value compass results at 2 and 4 years for IDH, SPS, and DS patients. The compass layout shows the results for surgical and nonoperative patients. The absolute change from baseline on ODI is on the west or "clinical" point of the compass, the change from baseline on PF is on the north or "functional" point of the compass, the PTS is on the east "satisfaction" point of the compass, and the CSC is on the south "cost" point of the compass. Higher absolute values on the ODI, PF, and PTS reflect better results for patients, whereas greater costs reflect higher expenses incurred by patients. The values in the center of the compass show the QALY results as well as the ICER results. Values shown in blue are for surgical patients and values shown in yellow are for nonoperative patients.
The compasses shown in Figure 1 suggest that at 2 years (left display), IDH patients treated surgically and nonoperatively had large improvements in ODI and PF; however, the surgical patients had greater gains on these The compasses shown in Figure 2 for SPS patients have a pattern similar to that seen for IDH patients, but in this case the gains for both surgical and nonoperative patients on health outcomes are muted. After 2 years, both groups show improvement on the ODI and PF but the absolute value of the improvement is much less than for IDH patients. Once again surgical patients are markedly more satisfied with their results and have greater expenses. Surgery is associated with greater gains in QALYs at an incremental cost for surgery of $77,600 per QALY. After 4 years, health outcome and satisfaction results are for the most part sustained, but total costs continue to increase in both groups, whereas the incremental cost for surgery per QALY decreases to $59,400.
Finally, the compasses shown in Figure 3 for DS patients provide yet another variation on the patterns seen before. These findings are not muted when contrasted with the IDH patterns, but rather in some respects amplified. At 2 years, the surgical patients show much greater improvement on the ODI and PF and are much more satisfied but they have incurred much higher total costs. The difference in the gain in QALYs by surgical patients compared with nonoperative patients is not large, whereas the ICER for surgery is quite high ($115,600). The same general pattern holds after 4 years, but the nonoperative patients have doubled their total costs, whereas the surgical patients have increased but at a much lower rate. All of this produces a more favorable ICER of $64,300 down from $115,600.
DISCUSSION
Results Summary
SPORT findings indicate that, for the average patient, surgical treatment produced better health outcomes and higher satisfaction but was more costly. The cost-effectiveness results suggest that these better outcomes for surgery range from $34,355 (IDH) to $115,600 (DS) incremental costs per QALY at 2 years, but that these incremental costs decrease at 4 years, ranging from $20,600 (IDH) to $64,300 (DS). If we were to adopt a convention that cost-effectiveness ratios of <$100,000 per year are reasonable, then we might conclude that surgery is sufficiently cost-effective to 
Research Methods: Merits and Limitations
SPORT has methodological limitations that have been discussed in prior reports. [4] [5] [6] [7] [8] [9] [10] This paper used an "as-treated" analysis combining both the randomized and observational groups as the basis for the findings. Although this is a reasonable choice, because it enables inclusion of all patients with follow-up data, it also dilutes the benefits of focusing solely on patients who were part of the RCT. Other limitations include: (1) patients who were lost to follow-up over time; (2) heterogeneity in treatments within and across centers; and (3) reliance on patient reports of utilization of care and role limitations to develop estimates of the costs of care because claims data were not available. Nevertheless, the pattern of the results between treatment groups was consistent and provides important insights on longitudinal outcomes, comparative effectiveness, and the tradeoffs involved in choosing between surgical and nonsurgical care.
Relevance of SPORT Trial to Critical Issues
In closing, we briefly touch on the relevance of SPORT to important policy issues.
Patient-centered Care Supported by Patientreported Outcome Measures
The need for patient-centered care delivery and research is clear, yet the use of patient-reported outcome measures as key endpoints in research has been limited. SPORT contributes to the movement toward acceptance of patient-reported outcome measures as being credible, valid, and reliable endpoints for certain diagnoses. The SPORT team is working to provide individual patients with better estimates of value compass treatment outcomes (based on using results from patients with similar characteristics) and thereby refine the data used for shared decision making. The SF-36 physical function score range from 0 to 100, with higher score indicating less severe symptoms. z
The ODI ranges from 0 to 100, with lower scores indicating less severe symptoms. y Combines and averages the "very" and "somewhat" satisfied with care responses (%).
Health Information Technology (HIT) Infrastructure
Although enormous resources are being invested in and electronic health records for use in clinical practice, and "meaningful use" has become the target of HIT development, deployment, and financial incentives, 25 the need for HIT to support the routine collection and analysis of patientreported outcome data has lagged behind. SPORT underscores the importance of building standard measures of patient-reported outcomes into clinical trials as well as into electronic health records, patient-controlled health records, and clinical/research registries for measuring longitudinal outcomes and costs. This practice would allow every patient encounter to become a datapoint, thus bridging the gap between clinical research and clinical practice.
Value Measurement for Care Improvement and Health Care Reform
SPORT offers a model that can be adopted for other clinical populations to measure outcomes in relationship to costs for specific clinical populations over time, that is, value. Value measurement should include health outcomes that are most relevant to patients, clinicians, and payers as well as measures of patient experience and costs of care. 23, 26, 27 We believe the methods we have used to summarize the results from SPORT for spine patients could be applied to many other clinical populations. Measures of value are needed to improve both clinical effectiveness as well as health care payment reform that reward the value of care experienced by patients as opposed to the volume of services delivered to patients. The value compass display provides a way to present complex data to summarize results published separately in many different papers. In the future, graphical displays can be used by patients to help them make more informed decisions based on customized estimates of results for "patients like me." 
